NCT01399619 · Interventional trial
Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)
Overall registry status Completed
Phase 3
Conditions Hepatitis C, Chronic
Delaware Valley sites
- 1220.19.0013 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory